In spite of the observed association of sST2 with increased sP-selectin and monocyte TF expression, the present study showed that sST2 is not capable to identify PAD patients at higher risk for poor outcomes following angioplasty and stenting. The gene discussed is TF; the disease is peripheral arterial disease.